SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Straumann Holding AG SAUHF OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • CH • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Straumann Holding AG (SAUHF) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $115.85. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $2.6B, +3.9%/yr average growth. Net income is $358M, growing at +2.2%/yr. Net profit margin is 13.7% (healthy). Gross margin is 68% (-7.6 pp trend).

Balance sheet: total debt is $651M against $2.2B equity (Debt-to-Equity (D/E) ratio 0.3, conservative). Current ratio is 2.21 (strong liquidity). Debt-to-assets is 17%. Total assets: $3.8B.

Analyst outlook: 1 / 1 analysts rate SAUHF as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 45/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 65/100 (Partial), Future 100/100 (Pass), Income 55/100 (Partial).

SAUHF SharesGrow Score Overview

69/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 15/100

Valuation — P/E, PEG, Forward PEG

GROWTH 45/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 65/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SAUHF

SAUHF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SAUHF: +3.9%/yr revenue is, +2.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SAUHF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SAUHF: Debt-to-Equity (D/E) ratio 0.3 (conservative), Current ratio is 2.21 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SAUHF: Gross margin is 68% (-7.6 pp trend), $18B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 65/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 1 analysts rate SAUHF as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SAUHF: Net profit margin is 13.7%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range93.18-139.59

Volume530

Avg Volume (30D)1.28K

Market Cap$18.47B

Beta (1Y)1.42

Dividend Yield$2.0249

Share Statistics

EPS (TTM)2.24

Shares Outstanding$159.82M

IPO Date2010-02-22

Employees11,342

CEOGuillaume Daniellot

Financial Highlights & Ratios

Revenue (TTM)$2.61B

Gross Profit$1.77B

EBITDA$696.4M

Net Income$358.17M

Operating Income$538.19M

Total Cash$489.8M

Total Debt$651.03M

Net Debt$175.37M

Total Assets$3.82B

Price / Earnings (P/E)51.7

Price / Sales (P/S)7.09

Analyst Forecast

Rating ConsensusBuy

Analysts Covering1

Buy 100% Hold 0% Sell 0%

Company Info

CountryCH

ExchangeOther OTC

CurrencyUSD

ISINCH1175448666

Price Chart

SAUHF

Straumann Holding AG ↗ · Other OTC

Healthcare • Medical - Instruments & Supplies

93.18 52WK RANGE 139.59

People Also View

EssilorLuxottica S.A.

EssilorLuxottica S.A.

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

Straumann Holding AG

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message